Cas:33162-17-3 2,8-Dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido-[4,3-b]indole dihydrochloride manufacturer & supplier

Chemical Name:2,8-Dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido-[4,3-b]indole dihydrochloride

CAS.NO:33162-17-3

Synonyms:Carbidine;carbidine dihydrochloride

Molecular Formula:C₁₃H₂₀Cl₂N₂

Molecular Weight:275.21700

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:305.7ºC at 760mmHg

Density:1.043g/cm3

Index of Refraction:

PSA:15.27000

Exact Mass:274.10000

LogP:3.88810

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Carbidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,carbidine dihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Carbidine Use and application,carbidine dihydrochloride technical grade,usp/ep/jp grade.

Related News: “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.” 2,8-Dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido-[4,3-b]indole dihydrochloride manufacturer It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad. 2,8-Dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido-[4,3-b]indole dihydrochloride supplier “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.” 2,8-Dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido-[4,3-b]indole dihydrochloride vendor However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future. 2,8-Dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido-[4,3-b]indole dihydrochloride factory In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available.